ClinicalTrials.Veeva

Menu
W

Women's Health Care Research | San Diego, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Fluconazole
LF111
Drospirenone
Estradiol
VeraCept
PP4001
Elagolix
LevoCept
MR-100A-01

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 15 total trials

Evaluation of Efficacy, Safety and Tolerability of VeraCept IUD

To assess the contraceptive efficacy (prevention of pregnancy) of VeraCept

Active, not recruiting
Women at Risk for Pregnancy
Drug: VeraCept

To assess the contraceptive efficacy (prevention of pregnancy) of LevoCept

Begins enrollment in 5 months
Contraception
Women at Risk for Pregnancy
Drug: LevoCept

The primary objective of this study is to evaluate the impact of LF111 and drospirenone (DRSP) 3.5 mg chewable tablets on bone mineral density (BMD)...

Enrolling
Change in Bone Mineral Density
Bone Loss
Drug: LF111 (drospirenone 4 mg oral tablet) or drospirenone (DRSP) 3.5 mg chewable tablet

Study of the contraceptive efficacy, cycle control, safety, and tolerability of MR-100A-01 in approxmiately 1200 women for up to 13 cycles

Active, not recruiting
Contraception
Drug: MR-100A-01

Trial sponsors

C
S
S
AbbVie logo
Becton, Dickinson and Company (BD) logo
I
Mylan logo
N
Organon logo
P

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems